Market Cap 96.10M
Revenue (ttm) 0.00
Net Income (ttm) -111.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,511,900
Avg Vol 5,613,764
Day's Range N/A - N/A
Shares Out 163.75M
Stochastic %K 17%
Beta 3.18
Analysts Strong Sell
Price Target $10.00

Company Profile

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company's lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone de...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 825 6990
Address:
171 Oyster Point Boulevard, Suite 500, South San Francisco, United States
Raumerica
Raumerica Feb. 25 at 12:20 AM
$TNYA Keep lying and bashing FUDster! Daddy wants more shares!
1 · Reply
Abzino88
Abzino88 Feb. 24 at 9:44 PM
$TNYA your absolutely wrong bud!!! they actually now own 49million shares …. before their transactions they had 59million. proof attached! stop spreading lies
1 · Reply
Spinaroonie
Spinaroonie Feb. 24 at 9:22 PM
$TNYA well who wants to say im right now!! Major investor dumps ALL their shares
1 · Reply
Ron_Burn
Ron_Burn Feb. 24 at 5:10 PM
$TNYA here's where things start to get interesting
1 · Reply
Cel55
Cel55 Feb. 24 at 4:55 PM
$TNYA His claim that I don’t even own shares here is less a rational argument and more a projection of his own inner insecurity and heightened sense of threat. When someone struggles to manage their anxiety, they often resort to unconscious defense mechanisms—accusing others of having hidden motives, manipulating narratives, or playing roles. Am I you, that I would spend this much time and energy analyzing and commenting on something I have no stake in? This accusation is not grounded in evidence but in a paranoid construction, where firm conclusions are drawn without concrete data—typically a sign of difficulty tolerating uncertainty. By constantly distorting the intentions of others, he is likely attempting to compensate for his own sense of lost control. If he fails to recognize and regulate this cycle of projection and suspicion, he risks drifting toward a more rigid mental framework in which his connection to reality weakens and he increasingly perceives others as threats.
6 · Reply
wei999999
wei999999 Feb. 24 at 3:50 PM
$TNYA loaded 30k more
1 · Reply
Crazyrussiankid
Crazyrussiankid Feb. 24 at 3:40 PM
$TNYA will rise again…
0 · Reply
Cel55
Cel55 Feb. 24 at 6:51 AM
$TNYA The SEC Form 144 filings show that the shares sold on February 10, 11, and 20, 2026 were originally acquired on July 31, 2017 and December 20, 2018 as part of the Series A financing. This indicates that the funds of The Column Group that invested in Tenaya Therapeutics during that period are now in the final phase of a typical 9–10 year venture capital fund lifecycle. The fact that the February 20 sale is tied to the same acquisition dates suggests that these transactions are more closely related to the fund’s maturity structure and its obligation to return capital to limited partners (LPs), rather than to the company’s short-term stock price movements. Therefore, these sales can be characterized as a structural fund exit and should not, on their own, be interpreted as a signal of operational or clinical deterioration
4 · Reply
KyleD91
KyleD91 Feb. 24 at 3:02 AM
$TNYA this stocks already split. Your investment in half
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Feb. 24 at 2:56 AM
0 · Reply
Latest News on TNYA
Tenaya Stock Plunges After $60 Million Equity Offering

Dec 12, 2025, 1:56 PM EST - 2 months ago

Tenaya Stock Plunges After $60 Million Equity Offering


Tenaya Therapeutics Announces Pricing of Public Offering

Dec 12, 2025, 12:16 AM EST - 2 months ago

Tenaya Therapeutics Announces Pricing of Public Offering


Tenaya Therapeutics Announces Proposed Public Offering

Dec 11, 2025, 4:02 PM EST - 2 months ago

Tenaya Therapeutics Announces Proposed Public Offering


Tenaya Therapeutics Announces Research Leadership Updates

Jun 27, 2024, 5:00 PM EDT - 1 year ago

Tenaya Therapeutics Announces Research Leadership Updates


Raumerica
Raumerica Feb. 25 at 12:20 AM
$TNYA Keep lying and bashing FUDster! Daddy wants more shares!
1 · Reply
Abzino88
Abzino88 Feb. 24 at 9:44 PM
$TNYA your absolutely wrong bud!!! they actually now own 49million shares …. before their transactions they had 59million. proof attached! stop spreading lies
1 · Reply
Spinaroonie
Spinaroonie Feb. 24 at 9:22 PM
$TNYA well who wants to say im right now!! Major investor dumps ALL their shares
1 · Reply
Ron_Burn
Ron_Burn Feb. 24 at 5:10 PM
$TNYA here's where things start to get interesting
1 · Reply
Cel55
Cel55 Feb. 24 at 4:55 PM
$TNYA His claim that I don’t even own shares here is less a rational argument and more a projection of his own inner insecurity and heightened sense of threat. When someone struggles to manage their anxiety, they often resort to unconscious defense mechanisms—accusing others of having hidden motives, manipulating narratives, or playing roles. Am I you, that I would spend this much time and energy analyzing and commenting on something I have no stake in? This accusation is not grounded in evidence but in a paranoid construction, where firm conclusions are drawn without concrete data—typically a sign of difficulty tolerating uncertainty. By constantly distorting the intentions of others, he is likely attempting to compensate for his own sense of lost control. If he fails to recognize and regulate this cycle of projection and suspicion, he risks drifting toward a more rigid mental framework in which his connection to reality weakens and he increasingly perceives others as threats.
6 · Reply
wei999999
wei999999 Feb. 24 at 3:50 PM
$TNYA loaded 30k more
1 · Reply
Crazyrussiankid
Crazyrussiankid Feb. 24 at 3:40 PM
$TNYA will rise again…
0 · Reply
Cel55
Cel55 Feb. 24 at 6:51 AM
$TNYA The SEC Form 144 filings show that the shares sold on February 10, 11, and 20, 2026 were originally acquired on July 31, 2017 and December 20, 2018 as part of the Series A financing. This indicates that the funds of The Column Group that invested in Tenaya Therapeutics during that period are now in the final phase of a typical 9–10 year venture capital fund lifecycle. The fact that the February 20 sale is tied to the same acquisition dates suggests that these transactions are more closely related to the fund’s maturity structure and its obligation to return capital to limited partners (LPs), rather than to the company’s short-term stock price movements. Therefore, these sales can be characterized as a structural fund exit and should not, on their own, be interpreted as a signal of operational or clinical deterioration
4 · Reply
KyleD91
KyleD91 Feb. 24 at 3:02 AM
$TNYA this stocks already split. Your investment in half
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Feb. 24 at 2:56 AM
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Feb. 24 at 1:53 AM
$TNYA pardon me, i got out long ago. would anyone happen to know where the bottom is? i would like to sign up
2 · Reply
AutisticRetardo
AutisticRetardo Feb. 23 at 8:08 PM
$TNYA TA'ing a clinical-stage biotech stock with no revenue:
1 · Reply
Rolfthewild
Rolfthewild Feb. 23 at 7:29 PM
$TNYA 😆 😆 Ohhh boyy if I'm right. Chips are in!
1 · Reply
Raumerica
Raumerica Feb. 23 at 5:36 PM
$TNYA Yes … that’s it! Doom and gloom!
0 · Reply
Raumerica
Raumerica Feb. 23 at 5:35 PM
$TNYA Nooo..Keep bashing… Don’t ask questions!
0 · Reply
Raumerica
Raumerica Feb. 23 at 5:34 PM
$TNYA Keep it up bashers and FUDsters… Daddy wants more!
0 · Reply
Cel55
Cel55 Feb. 23 at 5:19 PM
$TNYA Last year during March–April–May, there were also delisting and reverse split rumors, and everyone was anxious; prices were pressured by fear. In such times, the market often overreacts — while some panic and sell, disciplined investors who manage their risk can find opportunities. Sometimes, to win, you have to buy fear where the crowd is running away.
0 · Reply
LimSic
LimSic Feb. 23 at 5:00 PM
$TNYA Will stock prices skyrocket just because clinical trials are overwhelming effective?
1 · Reply
wins2love
wins2love Feb. 23 at 4:29 PM
$TNYA I think this is the definition of ride or die! 😎 If the chute doesn’t open soon, the bounce (if you can call it that) will be the kind you don’t remember.
0 · Reply
Raumerica
Raumerica Feb. 23 at 4:01 PM
$TNYA Thanks Boys and Girls! Gimme more… My appetite for TNYA shares is insatiable! Bash harder LimSic and Spinaroonie…
1 · Reply
blocktrade
blocktrade Feb. 23 at 3:56 PM
$TNYA shows a lot of confidence when the biggest shareholder is dumping 4 mm shares per week at the lows
2 · Reply
Kmth01
Kmth01 Feb. 23 at 3:38 PM
$TNYA FYI… The $0.60 Support: The stock hit a daily low of $0.60 this morning. If it breaks below this with a sudden spike in volume (e.g., another 1M+ share block), it could indicate a further exit by a large holder. Relative Volume: Today’s "Relative Volume" is currently around 0.95, meaning it's trading at a pace very close to its typical daily average. This suggests that, for now, we aren't seeing a major new block hitting the market this morning. The Resistance Ceiling: Every time the stock attempts to push toward $0.64, it has been met with selling pressure, likely from the "overhang" created by those large February blocks.
2 · Reply